The global eClinical solutions market was valued at USD 3.5 billion in 2017 and is projected to exhibit a CAGR of 11.2 percent during 2018 –...
The global non-invasive biosensors market was valued at USD 2.7 billion in 2017 and is projected to exhibit a CAGR of 12.1 percent during 2018–2026. Increasing...
Drug firm Strides Shasun has sought shareholders’ nod to change its name to Strides Pharma Science. This is the second time in three years’ time, when...
Drug maker Aurobindo Pharma’s net profit declined 0.65 percent to ₹528.8 crore in the quarter ended March, missing analyst estimates. The company posted net profit of ₹532.2 crore...
Glenmark’s consolidated revenue for Q4FY18 declined by 7.2 percent YoY to ₹2279.8 crore. Consolidated EBITDA declined by 26.4 percent YoY to ₹326.8 crore vs. ₹443.8 crore in Q4FY17. EBITDA...
Bihar Chief Minister Nitish Kumar on Monday inaugurated and laid foundation stones for a total of 301 medical-related infrastructural projects worth ₹784 crore and announced that state...
The draft advisory from the Delhi government on proposed new norms for private hospitals has invited subdued reactions from a few private facilities operating in the...
The Munjal-Burman combine, the investor recommended by the erstwhile board for taking over Fortis Healthcare India Ltd (FHIL), on Monday wrote to the Fortis management to...
Nursing homes and hospitals have welcomed a proposal by the Delhi government to cap profit margins of private hospitals and regulate the costs of medicines, diagnostics...
The UT Administration on Monday asked the Punjab and Haryana High Court to issue directions to Punjab and Haryana to improve healthcare facilities around Chandigarh for...
India’s largest hospital chain Apollo, Dubai-based Aster DM and Bengaluru-based Narayan Health in partnership with the Piramal group have emerged as the early bidders for the...
The Hero Enterprise-Burman family combine has withdrawn its binding offer to take over Fortis Healthcare and given its consent to the hospital chain’s board to reopen...
The most commonly consumed vitamin and mineral supplements provide no consistent health benefit or harm, a study has found. Researchers from the St Michael’s Hospital and...
Genmab A/S announced today that following a planned review, the DMC has recommended that the Phase Ib/II study (CALLISTO/LUC2001) of daratumumab in combination with atezolizumab versus...
Biocartis Group NV, an innovative molecular diagnostics company, announces the publication of a study in the Journal of Clinical Pathology demonstrating that the Idylla(TM) EGFR Mutation...
Copyright © 2026 Medical Buyer maintained by Algocept